We describe an infant with congenital mydriasis, patent ductus arteriosus (PDA), pulmonary hypertension, and cystic lung disease. She had all the major components of multisystemic smooth muscle dysfunction syndrome. Due to progressive respiratory deterioration, she required surgical PDA interruption, extracorporeal life support, and subsequent prolonged respiratory support. Genetic testing revealed ACTA2 R179H mutation and cystic lung disease on biopsy.
GuoDCPannuHTran-FaduluV. Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39(12):1488–1493.
2.
MilewiczDMOstergaardJRAla-KokkoLM. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet. 2010;152A(10):2437–2443.
3.
GrafMHJungherrA. Congenital mydriasis, failure of accommodation and patent ductus arteriosus. Arch Ophthalmol. 2002;120(4):509–510.
4.
LindbergKBrunvandL. Congenital mydriasis combined with aneurysmal dilatation of a persistent ductus arteriosus Botalli: a rare syndrome. Acta Ophthalmol Scand. 2005;83(4):508–509.
5.
LemireBDBuncicJRKenedySJDyackSJTeebiAS. Congenital mydriasis, patent ductus arteriosus and congenital cystic lung disease: new syndromic spectrum?Am J Med Genet. 2004;131(3):318–319.
6.
HoffjanSWaldmullerSBlankenfeldtW. Three novel mutations in the ACTA2 gene in German patients with thoracic aortic aneurysms and dissections. Eur J Hum genet. 2011;19(5):520–524.
7.
RoulezFMJFaesFDdelbekeP. Congenital fixed dilated pupils due to ACTA2—multisystem smooth muscle dysfunction syndrome. J Neuro-Ophthalmol. 2014;34(2):137–143.
8.
MunotPSaundersDEMilewiczDM. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain. 2012;135(pt 8):2506–2514.
